ID: ALA411313

Max Phase: Preclinical

Molecular Formula: C32H38O7

Molecular Weight: 534.65

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(/C=C2\CCC/C(=C\c3ccc(OC4CCCCO4)c(OC)c3)C2=O)ccc1OC1CCCCO1

Standard InChI:  InChI=1S/C32H38O7/c1-34-28-20-22(12-14-26(28)38-30-10-3-5-16-36-30)18-24-8-7-9-25(32(24)33)19-23-13-15-27(29(21-23)35-2)39-31-11-4-6-17-37-31/h12-15,18-21,30-31H,3-11,16-17H2,1-2H3/b24-18+,25-19+

Standard InChI Key:  AFUOQMUCKYYYDR-SIHVKLMXSA-N

Associated Targets(Human)

11-beta-hydroxysteroid dehydrogenase 1 5910 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

11-beta-hydroxysteroid dehydrogenase 2 1168 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

J774.A1 2436 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

11-beta-hydroxysteroid dehydrogenase 1 202 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

11-beta-hydroxysteroid dehydrogenase 2 82 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 534.65Molecular Weight (Monoisotopic): 534.2618AlogP: 6.73#Rotatable Bonds: 8
Polar Surface Area: 72.45Molecular Species: NEUTRALHBA: 7HBD: 0
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 6.77CX LogD: 6.77
Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.35Np Likeness Score: -0.01

References

1. Liang G, Li X, Chen L, Yang S, Wu X, Studer E, Gurley E, Hylemon PB, Ye F, Li Y, Zhou H..  (2008)  Synthesis and anti-inflammatory activities of mono-carbonyl analogues of curcumin.,  18  (4): [PMID:18234497] [10.1016/j.bmcl.2007.12.068]
2. Lin H, Hu GX, Guo J, Ge Y, Liang G, Lian QQ, Chu Y, Yuan X, Huang P, Ge RS..  (2013)  Mono-carbonyl curcumin analogues as 11β-hydroxysteroid dehydrogenase 1 inhibitors.,  23  (15): [PMID:23800686] [10.1016/j.bmcl.2013.05.080]

Source